gip/glp-1 receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions Mechanisms of action and therapeutic
Description
Tapering protocols that reduce the shock of discontinuation
10.1186/s13287-017-0694-z Summary Keywords GLP-1, GLP-1RAs, T2DM, glucose, mechanism Citation He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B and Pang Z (2025) Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
Spielman LJ, Gibson DL, Klegeris A
In the UK, the drug was approved in 2007
doi: 10.1523/JNEUROSCI.0115-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar] 157.Antonsen KK, Klausen MK, Brunchmann AS, et al
Pediatric Endocrine Society obesity special interest G
